ClearPoint Neuro, Inc. (CLPT) stock
CLPTNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 28, 2026Score 4/3021% above fair value
$8.48−0.01 (-0.12%)
Close on Nov 13, 2026Market cap $271.82MP/E –Yield –
ClearPoint Neuro enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
ClearPoint Neuro's enterprise value was $300.58M on Nov 11, 2026, against $402.05M a year earlier. Over the last 5 years it ranged from $96.92M to $647.30M, with a median of $269.93M.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $300.58M | -20.9% |
| 2025 | Dec 31, 2025 | $379.88M | -5.7% |
| 2024 | Dec 31, 2024 | $402.74M | +181.9% |
| 2023 | Dec 29, 2023 | $142.87M | -14.5% |
| 2022 | Dec 30, 2022 | $167.06M | -16.0% |
| 2021 | Dec 31, 2021 | $198.78M | -16.7% |
| 2020 | Dec 31, 2020 | $238.51M | +262.9% |
| 2019 | Dec 31, 2019 | $65.73M | +383.5% |
| 2018 | Dec 31, 2018 | $13.59M | -21.9% |
| 2017 | Dec 29, 2017 | $17.40M | +121.9% |
| 2016 | Dec 30, 2016 | $7.84M | -70.6% |
| 2015 | Dec 31, 2015 | $26.64M | -47.8% |
| 2014 | Dec 31, 2014 | $51.04M | -38.9% |
| 2013 | Dec 31, 2013 | $83.59M | +14.9% |
| 2012 | Dec 31, 2012 | $72.76M | – |
See a number that looks wrong?